5 things you need to know to make connected medical devices

Bill Welch, Phillips-Medisize The estimated number of connected medical devices – devices connected to the Internet –is expected to increase from 10 billion to 50 billion over the next decade, according to the IBM Institute for Business Value. This is due to the ability for machine-to-machine communication through cloud computing and networks of data-gathering sensors,

Phillips-Medisize partners with college students and new graduates

Phillips-Medisize recently celebrated the individuals participating in the company’s internship and rotational programs with a summer event. During the event, they learned first- hand, from company executives, about their importance to the company. Phillips-Medisize this summer has 35 interns in a variety of careers such as engineering, maintenance, HR/training, IT, finance/accounting, health/safety/environmental, legal and corporate

The first step to navigating your combination product’s regulatory pathway: PMOA

Editor’s Note: This article is written by Winston Brown, VP of Global Quality & Regulatory Affairs at Phillips-Medisize. The drug-device combination product market is growing at a rapid pace. By 2019, it is expected that the global market for drug device combination products will reach $115.1 billion. This is nearly double its worth from $66

Phillips-Medisize buys drug-delivery-device focused developer Medicom

Phillips-Medisize said today it bought drug-delivery device focused device strategy, product design and development service group Medicom Innovation Partner for an undisclosed amount. The acquisition will allow Phillips-Medisize to improve its drug delivery device development, and will expand the company’s end-to-end injectable and inhalation device innovation service solutions, the company said. “This transaction is consistent

Phillips-Medisize invited to join Sanofi at Partnerships in Drug Delivery

Phillips-Medisize Corp. representatives Bill Welch, Chief Technology Officer, and Janne Turunen, Program Manager, will be part of the Sanofi presentation at the Partnership Opportunities in Drug Delivery (PODD) in Boston, Massachusetts on October 5, 2015. The PODD conference brings together leaders in the pharma/biotech industry for networking and presentations on the latest drug delivery technologies, as well as

Phillips-Medisize increases design and development capabilities

Phillips-Medisize Corporation announced today the completion of a 5,000 sq. ft. expansion to its Hudson, Wisconsin, Design and Development Center (DDC). This new space will be occupied with expanded biopharmaceutical drug delivery and medical device test engineering capabilities including test method development, test method validation, product characterization, design verification testing, and root cause analysis, among

Team effort creates medical device that outshines the competition

From design and manufacturing, all the way through to secondary operations and commercialization, Phillips-Medisize is among the more successful complete medical device manufacturers in the United States. The range of in-house capabilities, services, and expertise appealed to a major medical original equipment manufacturer that chose to partner with Phillips-Medisize in the design of a new medical device